Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2571721000168118 | norethisterone 1 mg + ethinyloestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 327125011000036119 | ethinylestradiol 35 microgram + norethisterone 1 mg tablet [21 tablets] (&) inert substance tablet [7 tablets], 28 tablets (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 447741000036119 | norethisterone 1 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| norethisterone 1 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | has MPUU | norethisterone 1 mg + ethinylestradiol 35 microgram tablet | true | Inferred relationship | Some | 1 | |
| norethisterone 1 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | has MPUU | inert substance tablet | true | Inferred relationship | Some | 2 | |
| norethisterone 1 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Is a | norethisterone 1 mg + ethinylestradiol 35 microgram tablet, 21 | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Pirmella 1/35 (21 x 1 mg/35 microgram tablets, 7 x inert tablets), 28 | Is a | True | norethisterone 1 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | |
| Pirmella 1/35 (21 x 1 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | has subpack | True | norethisterone 1 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | 1433686732 |
| norethisterone 1 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 3 x 28 | has subpack | True | norethisterone 1 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | 2018682421 |
| Brevinor-1 28 Day (21 x 1 mg/35 microgram tablets, 7 x inert tablets), 28 | Is a | True | norethisterone 1 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | |
| Norimin-1 28 Day (21 x 1 mg/35 microgram tablets, 7 x inert tablets), 28 | Is a | True | norethisterone 1 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | |
| Norimin-1 28 Day (21 x 1 mg/35 microgram tablets, 7 x inert tablets), 4 x 28 | has subpack | True | norethisterone 1 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | 1 |
| norethisterone 1 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 4 x 28 | has subpack | True | norethisterone 1 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | 1 |
| Brevinor-1 28 Day (21 x 1 mg/35 microgram tablets, 7 x inert tablets), 4 x 28 | has subpack | True | norethisterone 1 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | 1 |
Reference Sets
List of Medicines for Brand Consideration reference set
Medicinal product pack reference set
FHIR